Bill Text: US HB2855 | 2019-2020 | 116th Congress | Introduced
Bill Title: To deem the application submitted by Jaci Hermstad to the Food and Drug Administration for compassionate use of the gene therapy antisense oligonucleotides to be approved.
Spectrum: Partisan Bill (Republican 1-0)
Status: (Introduced - Dead) 2019-05-21 - Referred to the Subcommittee on Health. [HB2855 Detail]
Download: US_Congress-2019-HB2855-Introduced.pdf